Drug intelligence / Profile preview

Bactigyn

Development stage: Unknown
Lead developer: Laboratoire CCD
Modality: Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Bactigyn is a product line developed by Laboratoire CCD specifically for women's intimate health. The range includes both a Class IIa medical device in the form of vaginal ovules and an oral dietary supplement. The vaginal ovules contain tyndallized (heat-inactivated) *Lactobacillus rhamnosus* LRH020, lactic acid, sodium hyaluronate, and essential oils (tea tree and white thyme), designed to restore the vaginal ecosystem, balance pH, and treat or prevent infections like bacterial vaginosis and candidiasis. The oral capsules contain a blend of live probiotic strains (*L. rhamnosus* Rosell-11, *L. helveticus* Lafti L10, *L. brevis* HA-112, and *L. helveticus* Rosell-52) to support vaginal flora from within. These products work by promoting the restoration of the vaginal ecosystem, helping to balance vaginal flora, restore physiological pH, and alleviate symptoms such as itching, redness, and burning.

Brand names: Bactigyn

Beyond the preview

Go deeper on Bactigyn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bactigyn.

Explore the full profile